About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Pittsburgh | 476 Studies

Clinical Trials Breast CancerPittsburgh

Breast Cancer Clinical Trials in Pittsburgh

Find 476 clinical trials for breast cancer near Pittsburgh, Pennsylvania. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Pittsburgh

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 476 trials

CompletedCisplatin vs Paclitaxel for Triple Negative Breast CancerThis is a phase II study randomizing patients with stage I with T1 \> 1.5 cm, stage II or III triple negative breast cancer (TNBC) to preoperative cisplatin versus paclitaxel.NCT01982448·Birmingham, Alabama and 19 others CompletedMulticenter Hologic Tomosynthesis StudyThe purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective…NCT00971087·Scottsdale, Arizona and 21 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingAxillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionThis phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection.NCT03927027·Little Rock, Arkansas and 95 others

CompletedTherapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast CancerThe purpose of this study is to learn how breast cancer tumors respond to treatment combining the drugs docetaxel and ZD1839.NCT00052169·Pittsburgh, Pennsylvania

CompletedVeliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast CancerThis phase II trial studies how well veliparib with or without carboplatin works in treating patients with stage III or IV breast cancer.NCT01149083·Duarte, California and 22 others

RecruitingThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyThe Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based…NCT04075305·Pittsburgh, Pennsylvania and 17 others

CompletedStudy Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast CancerThe purpose of this study is to evaluate pembrolizumab therapy in patients with triple-negative breast cancer (TNBC) who have received at least one prior line of therapy.NCT02768701·Washington D.C., District of Columbia and 4 others

CompletedTreatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus PalbociclibTo assess longitudinal changes in allele frequency of ESR1 mutation in plasma in patients treated with Fulvestrant plus palbociclib compared to tamoxifen plus palbociclibNCT02913430·Pittsburgh, Pennsylvania

CompletedSafety Study of Modified Vaccinia Virus to CancerThe purpose of this study is to determine the safety and maximum tolerated dose from injecting this vaccinia virus into tumors or infusion.NCT00574977·Pittsburgh, Pennsylvania

CompletedStudy of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)CX-839-007 is an open-label Phase 2 study of the combination of CB-839 with paclitaxel in participants of African ancestry and non-African ancestry with advanced triple negative…NCT03057600·Birmingham, Alabama and 24 others

CompletedMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00036790·Pittsburgh, Pennsylvania and 1 other

CompletedThe Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerThe purpose of this study is to compare the efficacy of Faslodex (fulvestrant) to Aromasin (exemestane) in hormone receptor positive postmenopausal women with advanced breast…NCT00065325·Birmingham, Alabama and 116 others

Active not recruitingEntinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerThis phase I trial studies the side effects and best dose of entinostat and nivolumab when given together with ipilimumab in treating patients with solid tumors that have spread…NCT02453620·Duarte, California and 4 others

CompletedA Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerThe main purpose of this study is to learn if adding bevacizumab to standard treatment with chemotherapy (docetaxel, doxorubicin, and cyclophosphamide) for early stage…NCT00887536·Bessemer, Alabama and 532 others

RecruitingETHAN - ET for Male BCThis research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most…NCT05501704·Washington D.C., District of Columbia and 8 others

RecruitingEXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)The EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and…NCT06401421·Anchorage, Alaska and 60 others

UnknownCapecitabine in Metastatic Breast and GI CancersThe purpose of this study is compare different doses of capecitabine to see if one is better than the other in terms of efficacy and toxicity.NCT02595320·Fairway, Kansas and 14 others

CompletedA Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic CancersThis Phase 1b/2a study will assess the efficacy, safety, and pharmacodynamics of CyPep-1 when administered directly into measurable tumor lesions in combination with the anti-PD-1…NCT05383170·Birmingham, Alabama and 24 others

RecruitingStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid TumorsThis is a phase 1/1b, open-label, multicenter study consisting of sequential parts designed to evaluate the safety, tolerability, and effects pharmacokinetic (PK) profile, and…NCT07524322·Los Angeles, California and 5 others

Active not recruitingPhase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)The study is intended to show superiority of AZD9833 in combination with CDK4/6 inhibitor (palbociclib, abemaciclib or ribociclib) versus aromatase inhibitors (anastrozole or…NCT04964934·Phoenix, Arizona and 263 others

PreviousPage 3 of 24Next

Other Conditions in Pittsburgh

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma